Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy
暂无分享,去创建一个
K. Coppieters | J. Norlin | Lisbeth Nielsen Fink | Elisabeth Douglas Galsgaard | Peter Helding Kvist
[1] G. Remuzzi,et al. B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.
[2] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] M. Rastaldi,et al. Role of podocyte B7-1 in diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.
[4] T. Fujimura,et al. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. , 2014, American journal of physiology. Renal physiology.
[5] C. Daniel,et al. Podocytes are nonhematopoietic professional antigen-presenting cells. , 2013, Journal of the American Society of Nephrology : JASN.
[6] P. Fiorina,et al. Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? , 2012, Seminars in nephrology.
[7] J. Moon,et al. Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy , 2012, American Journal of Nephrology.
[8] C. Alpers,et al. Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[9] A. Krensky,et al. Mechanisms of Disease: regulation of RANTES (CCL5) in renal disease , 2007, Nature Clinical Practice Nephrology.
[10] Paul Garside,et al. Reversal of the TCR Stop Signal by CTLA-4 , 2006, Science.
[11] J. Egido,et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] R. Kalluri,et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.
[13] R. Atkins,et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.
[14] K. Ley,et al. Leukocyte recruitment and vascular injury in diabetic nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.